Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04832854
Title A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Hoffmann-La Roche

lung non-small cell carcinoma


Atezolizumab + Carboplatin + Pemetrexed Disodium + Tiragolumab

Atezolizumab + Carboplatin + Paclitaxel + Tiragolumab

Atezolizumab + Tiragolumab

Atezolizumab + Cisplatin + Pemetrexed Disodium + Tiragolumab

Atezolizumab + Carboplatin + Gemcitabine + Tiragolumab

Atezolizumab + Cisplatin + Gemcitabine + Tiragolumab

Cisplatin + Gemcitabine

Carboplatin + Gemcitabine

Carboplatin + Paclitaxel

Carboplatin + Pemetrexed Disodium

Cisplatin + Pemetrexed Disodium

Age Groups: adult | senior
Covered Countries USA | ESP

Additional content available in CKB BOOST